This Drug Deal May Be On AgainBy
A takeover of Allergan (AGN) was almost in the bag in early May, until Volvo blocked the acquisition--by drugmaker Pharmacia & Upjohn, of which the carmaker owns 14%. Now, it seems this maker of eye-care products and pharmaceuticals is back in play.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.